A Randomised Phase II Trial of Osimertinib With or Without SRS for EGFR Mutated NSCLC With Brain Metastases
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Chee Lee, Dr
National Health and Medical Research Council, Australia
Study Chair - Fiona Hegi-Johnson, Dr
Peter MacCallum Cancer Centre, Australia
Study Chair - Ivan Tham, Dr
National University Hospital, Singapore
Study Chair - Yu Yang Soon, Dr
National University Hospital, Singapore
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Calvary Mater
Newcastle, New South Wales, Australia
- Blacktown Hospital
Sydney, New South Wales, Australia
- Liverpool Hospital
Sydney, New South Wales, Australia
- St George Hospital
Sydney, New South Wales, Australia
- St. Vincents Hospital
Sydney, New South Wales, Australia
- Westmead Hospital
Sydney, New South Wales, Australia
- Icon Cancer Centre Greenslopes
Brisbane, Queensland, Australia
- Princess Alexandra Hospital
Brisbane, Queensland, Australia
- Royal Adelaide Hospital
Adelaide, South Australia, Australia
- Monash Health
Melbourne, Victoria, Australia
- Peter Maccallum Cancer Center
Melbourne, Victoria, Australia
- Sir Charles Gairdner
Perth, Western Australia, Australia
- National University Hospital
Singapore, Singapore
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Aug 2019
- Primary completion
- 30 Apr 2024
- Completion
- 30 Apr 2024
- Last update posted
- 31 May 2024
- Registered enrollment
- 40
- Registry id
- NCT03497767
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.